Monday July 16, 2018
Home India China will no...

China will not sit quietly if India boosts Military ties with Vietnam to counter Beijing, warns a Chinese Daily

China will not sit quietly if India boosts military ties with Vietnam to counter Beijing

0
//
53
activist in China
In China, Pixabay
Republish
Reprint

Beijing, Jan 11, 2017: China will not sit quietly if India boosts military ties with Vietnam to counter Beijing, a Chinese newspaper warned on Wednesday.

An op-ed in Global Times also told New Delhi not to “stir up troubles” in Southeast Asia.

“If the Indian government genuinely treats its enhancement of military relations with Vietnam as a strategic arrangement or even revenge against Beijing, it will only create disturbances in the region and China will hardly sit with its arms crossed,” said the daily which is said to represent the views of the Chinese leadership.

According to reports, India is in talks with Vietnam to sell indigenous surface-to-air missile system.

NewsGram brings to you top news around the world today.

“This was supposed to be a normal arms sale, yet was portrayed by the Indian media as a response ‘to counter the Chinese threat.'” the daily said.

It said it was natural for New Delhi to deepen its ties with Hanoi, which is a pillar of India’s Act East Policy.

It, however, cautioned that “such ties should be built for the sake of peace and stability in the region, rather than stirring up troubles or anxiety for others.

“However, when India and Vietnam are in talks about possible sales, New Delhi seems to keep taking a sneak peak at Beijing, as if the deal is stealthily aimed at China.”

NewsGram brings to you current foreign news from all over the world.

During an official visit to Hanoi in September 2016, Prime Minister Narendra Modi announced $500 million defence credit line to Vietnam, which is dubbed as “principal protagonist,” in the South China Sea –claimed by Beijing.

It said Indian experts and media describing Vietnam as China’s backyard reflected “India’s outdated diplomatic mindset”.

The article said “due to geopolitical factors, some nations have been cosying up to India over the years, which to a large extent contributed to India’s fruitful development.

“New Delhi understands that the best strategy for itself is to continue its collaboration with all parties, instead of picking a side and turning hostile to one another.

“Otherwise, it might not only turn others’ troubles to its own puzzles, but also suffer enormous losses of development opportunities.

“India has a dream to grow into a great power. But under today’s international circumstances, it will be extraordinarily hard to achieve the goal on its own.

“What India needs is more pragmatic cooperation with other countries.”

The newspaper, run by the China’s Communist Party, hoped that India will join the Belt and Road project.

Check out NewsGram for latest international news updates.

“This will help promote the country’s infrastructure construction, improve connectivity within the region and may even turn into a push to solve the India-Pakistan contradictions.”

India has been non-committal to China’s ambitious project. New Delhi has opposed the China Pakistan Economic Corridor, which passes through Pakistan-administered Kashmir claimed by India.

“It is hoped that the hype in the Indian media does not represent the country’s government. There are divergences between Beijing and New Delhi, yet there are more common interests that await the two to explore.” (IANS)

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)